A new market study, titled “Global Cancer Generics Market Forecast to 2022”, has been featured on WiseGuyReports.
Within the pharmaceutical industry, the oncology market is growing at a rapid pace owing to the rising incidences of cancer. In 2015, 15.2 Million new cancer cases were registered across the globe. This number is forecasted to increase to a value of 19.3 Million by 2025. Furthermore, the patent expiry of blockbuster cancer drugs is another major factor which is propelling the growth of the cancer generics industry.
As per report “Global Cancer Generics Market Forecast to 2022”, the global cancer generics market is anticipated to witness a double digit growth during 2016-2022. This report provides a detailed analysis of the current and future market scenario of the global cancer generics market. The report provides insight about the major drivers and challenges, along with the latest trends and developments impacting the industry growth. In addition, the report also highlights various opportunities available for growth of the global cancer generics market.
The global cancer generics market has been segmented on the basis of mode of administration into oral and injectables. Injectables are the most widely used type of cancer generics drugs. The report also highlights the major cancer generic drugs available in the global market.
Furthermore, the global cancer generics market has also been segmented on the basis of the major indications they are used for. According to the report, breast cancer is expected to account for the largest share in 2016 due to presence of large number of generic drugs and rising incidences of this indication.
Based on geography, the report divides market into North America, Europe, and Asia-Pacific. In 2016, North America is estimated to account for the largest share. Moreover, the report also lists down various mergers and acquisitions taking place in the global generics industry.
The last section of the report discusses about the prominent players in global cancer generics market. A brief business overview and financial information about each of these players has been provided, along with their product portfolios. The recent development of every player has also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global cancer generics market.
Request Sample Report at https://www.wiseguyreports.com/sample-request/1706470-global-cancer-generics-market-forecast-to-2022
Table of Content
- Analyst View
- Research Methodology
- Global Cancer Drugs Market Outlook 2022
- Market Drivers & Challenges
- Global Cancer Generics Market Analysis 2022
- Global Cancer Generics Market by Mode of Administration
- Global Cancer Generics Market by Major Indications
- Global Cancer Generics Market by Geographic Regions
- Trends & Developments
- Mergers & Acquisitions
- Key Players
11.1 Fresenius Kabi AG
11.2 Pfizer Inc
11.3 Teva Pharmaceutical Industries Ltd
11.4 Mylan N.V
11.5 Sun Pharmaceutical Industries Ltd
11.6 Sandoz International GmbH – A Novartis Company
11.7 Sanofi
11.8 Dr. Reddy’s Laboratories Ltd
11.9 Cipla Ltd
11.10 Apotex Inc
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Your information will never be shared with any third party.